Results 151 to 160 of about 31,348 (237)

Mechanisms of resistance to macrophage checkpoint inhibitors in B‐cell non‐Hodgkin lymphoma

British Journal of Haematology, EarlyView.
Zachary Hunzeker, Francisco Javier de la Rosa, Andrey Tyshevich, Darya Shavronskaya, Julia Alesse, Noel English, Lizzie Sheehan, Nikita Syzrantsev, Alexander Nesmelov, Hans‐Guido Wendel, Paolo Strati   +10 more
wiley   +1 more source

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry ...
Svenja Royeck, Henning Olbrich, Steffen Koschmieder, Claudia Zeidler, Felix Witte, Konstantin Agelopoulos, Henning Wiegmann, Michael Storck, Johannes Benedict Oehm, Ralf J. Ludwig, Sonja Ständer   +10 more
wiley   +1 more source

Rapidly progressing necrotic ulcerations and sinuses in specific cutaneous Hodgkin's disease.

Indian Dermatol Online J, 2016
George A, Peter D, Pulimood S, Manipadam MT, George B, Paul MJ, Thomas JK.   +6 more
europepmc   +1 more source

An assessment of selected immune parameters of patients with Hodgkin's disease. [PDF]

Mol Clin Oncol, 2015
Kołtan A, Kołtan S, Dębski R, Grześk E, Wysocki M, Grześk G.   +5 more
europepmc   +1 more source

Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital – a cross‐sectional study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Studies on the state of medical care for patients with cutaneous T‐cell lymphoma (CTCL) are limited. To date, only secondary data analyses are available for Germany. Patients and Methods Cross‐sectional study conducted over a one‐year recruitment period (01 March 2024 to 28 February 2025) in the dermatological department of a German ...
Inga Hansen‐Abeck, Larissa Kölln, Finn Abeck, Glenn Geidel, Stefan W. Schneider, Nina Booken   +5 more
wiley   +1 more source

Radiation-induced breast cancer in women with Hodgkin's disease. [PDF]

Rep Pract Oncol Radiother, 2014
Aleksandrova E, Mihaylova I, Sergieva S, Parvanova V, Ivanova D.   +4 more
europepmc   +1 more source

Acute Hodgkins Disease [PDF]

Acta Radiologica, 1952
openaire   +2 more sources

Case Report: Scar contracture caused by ruptured subcutaneous ganglion cyst misdiagnosed as Dupuytren's disease: diagnostic reflections on a rare case. [PDF]

Front Surg
Jiang K, Li G, Ma L, Liang XZ, Rong YF, Zhang J.   +5 more
europepmc   +1 more source

The different face of skin‐rash induced by brentuximab vedotin

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri, Tullio Brunetti, Serena Rupoli, Gianluca Cafasso, Corrado Zengarini, Staphano Cedirian, Federico Bardazzi, Cosimo Misciali, Michela Starace, Claudio Agostinelli, Gaia Goteri, Erika Morsia   +11 more
wiley   +1 more source

A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin's Lymphoma. [PDF]

JACC Case Rep
Baig AS, Jawed S, Gurmani S, Bhatti S.
europepmc   +1 more source